Answers are grounded in this paper and cite their sources.
Research uncovers core risk genes and develops a predictive model for Alzheimer's Disease, suggesting enhanced diagnostic capabilities.
Introduction: Alzheimer’s Disease (AD) is among the most prevalent neurodegenerative disorders globally, yet effective early diagnostic strategies remain lacking. Advances in multi-omics technologies and the integration of artificial intelligence into medicine have created new opportunities for developing predictive models for AD. Biomarker-based models hold significant promise for enhancing early detection. In this study, we integrated multi-omics data to identify core risk genes with potential causal links to AD and developed an early diagnostic model, thereby providing a theoretical framework for precision intervention. Methods: We integrated Mendelian Randomization (MR), differential expression analysis, and Weighted Gene Co-Expression Network Analysis (WGCNA) to identify candidate genes with potential causal relevance to AD. Functional enrichment analyses using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG), along with immune infiltration profiling, were performed to investigate the biological roles of these genes. We then applied eight machine learning algorithms to evaluate gene importance scores and selected the most diagnostically informative features to construct the Nomogram predictive model. The model's performance was validated in an independent external cohort. Finally, Gene Set Enrichment Analysis (GSEA) was conducted to further elucidate the mechanistic involvement of core risk genes in AD pathogenesis. results: Candidate genes potentially causally associated with AD were identified from large-scale genomic data through Mendelian Randomization (MR) analysis, differential expression analysis (DEGs), and Weighted Gene Co-Expression Network Analysis (WGCNA). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were subsequently conducted, and immune cell infiltration characteristics were evaluated using the CIBERSORT algorithm. The importance scores of genes were assessed using eight machine learning algorithms, and key feature variables were selected. A nomogram prediction model was constructed, and its performance was validated using an external dataset. GSEA analysis further revealed the potential biological functions of core risk genes in AD, suggesting their key roles in disease progression, with significant clinical application prospects.Immune cell analysis finds that the enrichment of M2 macrophages may exacerbate the immunosuppressive state of AD. Results: Integrated analyses using multiple machine learning models (all with AUC values exceeding 0.88) identified VASP, PIP4K2A, RRP36, METTL7A, and AP2M1 as key diagnostic feature genes. The nomogram constructed based on these five genes demonstrated robust diagnostic performance in the validation cohort (AUC = 0.964). Notably, RRP36 and PIP4K2A consistently emerged as core risk genes across diverse machine learning approaches. GSEA results further suggested that RRP36 may contribute to neurodegeneration by modulating cytoskeletal remodeling and neuroinflammatory responses, while PIP4K2A may be implicated in synaptic dysfunction. discussion: This study identifies core risk genes associated with Alzheimer's disease (AD) through bioinformatics analysis and machine learning algorithms,and constructs a diagnostic model based on multiple genetic features.MRDEGs play a significant role in the onset and progression of AD through co-expression or interactions.GO enrichment analysis suggests that these genes may be involved in the pathological progression of AD by regulating processes such as microtubule organization center and glial cell migration.KEGG pathway analysis further reveals that calcium homeostasis imbalance may exacerbate cognitive impairment in AD.Machine learning models (e.g., RF model) identified five key genes (VASP, PIP4K2A, RRP36, METTL7A, and AP2M1),and constructed a risk nomogram model based on these genes, providing a tool for early screening.RRP36 and METTL7A were identified as core risk genes,with high expression of RRP36 being associated with mitochondrial function and protein homeostasis, and low expression of METTL7A potentially linked to synaptic dysfunction.Despite the progress made, there are limitations such as the homogeneous population structure and potential biases,future studies should expand sample diversity and further explore the functional mechanisms of these genes. Discussion: This study is the first to integrate MR, differential gene expression, and WGCNA for systematic AD risk gene discovery, combined with a multi-algorithm machine learning strategy to enhance model robustness and translational potential. RRP36 and PIP4K2A, as core risk genes, may drive AD progression by orchestrating cytoskeletal reorganization, neuroinflammation, and synaptic impairment, offering promising targets for future mechanistic investigations and therapeutic development. Conclusion: This study identified and validated RRP36 and METTL7A as core risk genes for AD. The resulting nomogram, based on a five-gene panel, exhibited high diagnostic accuracy and provides new biomarkers and methodological support for the early screening and precise intervention of AD.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: